Literature DB >> 12604863

Stent implantation and subsequent dilatation for pulmonary vein stenosis in pediatric patients: maximizing effectiveness.

Hideshi Tomita1, Ken Watanabe, Satoshi Yazaki, Kohji Kimura, Yasuo Ono, Toshikatsu Yagihara, Shigeyuki Echigo.   

Abstract

The outcome of stent implantation and redilatation was investigated in 4 pediatric patients with 7 stenotic lesions of the pulmonary vein (PV), paying particular attention to late neointimal proliferation. The minimal diameter of the lesions increased from 0.8-3.6 (2.3+/-1.1) mm to 3.6-8.4 (5.1+/-1.6) mm immediately after stent implantation. Although the pressure gradient across the lesion was not measured in patient 4, in patients 1-3, it decreased from 4-34 (18+/-13) mmHg to 3-15 (7+/-4) mmHg. Except for case 4, who achieved a lesion diameter of 8.4 mm after initial stent dilatation, the other 6 lesions all restenosed within a few months, with an increasing pressure gradient. One patient with multiple PV stenoses associated with persistent severe pulmonary hypertension died suddenly. However, repeat dilatations were effective in all other lesions. Furthermore, in one lesion in patient 1, no serious restenosis developed for 20 months after the lesion was dilated up to 5.6 mm. Although further follow-up is mandatory, the final stent diameter within a vessel may determine long-term patency, and aggressive redilatation may be crucial for successful therapy of such a difficult disease.

Entities:  

Mesh:

Year:  2003        PMID: 12604863     DOI: 10.1253/circj.67.187

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

Review 1.  Pulmonary vein stenosis: Etiology, diagnosis and management.

Authors:  Pablo Pazos-López; Cristina García-Rodríguez; Alba Guitián-González; Emilio Paredes-Galán; María Ángel De La Guarda Álvarez-Moure; Marta Rodríguez-Álvarez; José Antonio Baz-Alonso; Elvis Teijeira-Fernández; Francisco Eugenio Calvo-Iglesias; Andrés Íñiguez-Romo
Journal:  World J Cardiol       Date:  2016-01-26

2.  Drug-eluting stents ameliorate pulmonary vein stenotic changes in pigs in vivo.

Authors:  Takeshi Furukawa; Masahiko Kishiro; Hideo Fukunaga; Masahiro Ohtsuki; Ken Takahashi; Katsumi Akimoto; Toshiaki Shimizu; Shiori Kawasaki; Toshio Kumasaka
Journal:  Pediatr Cardiol       Date:  2010-05-04       Impact factor: 1.655

3.  Breakable stent for interventions in infants and neonates: an animal study and histopathological findings.

Authors:  M Sigler; K Schneider; M Meissler; K Koenig; M B E Schneider
Journal:  Heart       Date:  2005-04-29       Impact factor: 5.994

4.  Cryo-balloon angioplasty for pulmonary vein stenosis in pediatric patients.

Authors:  Michael A Bingler; Jeffrey R Darst; Thomas E Fagan
Journal:  Pediatr Cardiol       Date:  2011-09-03       Impact factor: 1.655

5.  Pulmonary vein stenosis: Case report and literature review.

Authors:  R Amin; S Kwon; Y Moayedi; N Sweezey
Journal:  Can Respir J       Date:  2009 Nov-Dec       Impact factor: 2.409

6.  Total Anomalous Pulmonary Vein Connection: Diagnosis, Management, and Outcome.

Authors:  Mathias Emmel; Narayanswami Sreeram
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

7.  Pulmonary vein stents in infants and children: is there lasting benefit?

Authors:  N Sreeram; M Emmel; U Trieschmann; K Brockmeier; G Bennink
Journal:  Clin Res Cardiol       Date:  2008-03-17       Impact factor: 5.460

8.  Paclitaxel drug-eluting stent placement for pulmonary vein stenosis as a bridge to heart-lung transplantation.

Authors:  Andreea Dragulescu; Olivier Ghez; Jacques Quilici; Alain Fraisse
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

Review 9.  The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment.

Authors:  Yuichi Matsuzaki; Matthew G Wiet; Brian A Boe; Toshiharu Shinoka
Journal:  Biomedicines       Date:  2021-04-27

10.  Why can pulmonary vein stenoses created by radiofrequency catheter ablation worsen during and after follow-up? A potential explanation.

Authors:  Pierre-André Doriot; Pierre-André Dorsaz; Dipen Chandrakant Shah
Journal:  J Cardiothorac Surg       Date:  2008-05-05       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.